Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
SmithKline Beecham Holdings Corporation history
SmithKline Beecham Holdings Corporation company history timeline
Also in 1996 came the launch of the pharmaceutical Hycamtin, which was designed to treat ovarian cancer and small cell lung cancer.
The following year, SmithKline joined with Incyte Pharmaceuticals to create another biotechnology venture called diaDexus. Therefore, in 1996 the company began licensing the Human Genome Sciences data to other pharmaceutical companies, including Schering-Plough Corporation, Takeda Chemical Industries Ltd., and Merck.
1998:Company enters advanced mergers talks with Glaxo Wellcome, but the deal falls through.
In 1999, the company launched Avandia (rosiglitazone maleate), for the treatment of type2 diabetes, in the US.
More than a century and many new formations and mergers later, Glaxo Wellcome acquired SmithKline Beecham in 2000 to form GlaxoSmithKline.
GSK today: 2000 – present
GSK launched the African Malaria Partnership in 2001, boosting the global awareness of the disease that kills over one million people every year.
2001 SmithKline Beecham and Glaxo Wellcome merged in a $75.7 billion stock deal.
Around this same time, the company announced a four-year restructuring plan in which it would close down excess manufacturing plants and lay off about 3,000 people, resulting in annual savings of £200 million (US$332 million) by 2002.
On th July 2003, ten million people in Sri Lanka received these free doses.
2004 GSK launches the Clinical Trial Register, containing clinical trial data accessible to anyone
Bill Gates, founder of the Bill &, Melinda Gates Foundation highlights GSK in recognition of the company’s commitment to R&,D on malaria, five years later in 2005.
By the end of 2006, GSK had donated 600 million treatments, and found itself as the recipient of the New Business Award.
Andrew Witty succeeded JP Garnier as Chief Executive Officer (CEO) in 2008.
GSK is currently first on the “Access to Medicines Index” and has been on the top of the list since its inception in 2008.
Drugwatch.com has provided reliable, trusted information about medications, medical devices and general health since 2008.
In 2009, GlaxoSmithKline announced its plan to cut drug prices by 20 percent in 50 of the world’s poorest nations.
In 2009, the plant closed after failed attempts to fix the plant after an FDA investigation.
2009 Philadelphia jurors awarded $2.5 million in a Paxil lawsuit filed by the family of a 3-year-old born with severe heart malformations.
2009 GSK and Pfizer launch ViiV Healthcare
Using the expertise of both companies and Shionogi, who joined in 2012, ViiV Healthcare now has a portfolio of thirteen HIV treatments.
Palmer, E. (2014, December 4). GSK makes deep job cuts as Advair sales crash fast.
A Chinese court ordered GlaxoSmithKline to pay $492 million in 2014.
2015 GSK and Novartis transaction completed
2016 GSK paid $6.2 million to settle a Canada class action lawsuit involving 50 mothers and their children.
Wong, G. (2017, April 21). $3 million awarded to widow who sued pharmaceutical firm over husband’s suicide.
In February 2018, GSK was still answering to fraud investigators in its home country.
Palmer, E. (2018, February 7). GlaxoSmithKline notifies SEC, DOJ of new questions in China bribery probe.
In 2018, it was ranked the fifth-largest pharmaceutical company in the world based on revenue of about $43 billion.
GSK is ranked number 6 among the top 20 pharma companies by revenue in 2019, according to FiercePharma.
Total revenues for GSK reached $34 billion pounds in 2020.
GSK faced 476 federal Zofran lawsuits in February 2021.
"Smithkline Beecham PLC ." International Directory of Company Histories. . Retrieved June 21, 2022 from Encyclopedia.com: https://www.encyclopedia.com/books/politics-and-business-magazines/smithkline-beecham-plc-0
© 2022 Drugwatch.com Privacy Policy / Advertising Disclosure / Do Not Sell My Info
Rate how well SmithKline Beecham Holdings Corporation lives up to its initial vision.
SmithKline Beecham Holdings Corporation jobs
Do you work at SmithKline Beecham Holdings Corporation?
Is SmithKline Beecham Holdings Corporation's vision a big part of strategic planning?
SmithKline Beecham Holdings Corporation competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Allergan plc | 1948 | $7.2B | 11,400 | 49 |
| Merial Limited | 1981 | $2.7B | 6,900 | - |
| Roche Diagnostics Middle East | 2012 | $53.0M | 635 | - |
| Wyeth Biopharma | 1860 | $22.4B | 49,732 | - |
| Novartis | 1996 | $51.7B | 110,000 | 376 |
| Roche Holding AG | 1987 | $61.0B | 94,442 | 247 |
| Boehringer Ingelheim | 1984 | $17.2B | 52,391 | 372 |
| Forest Laboratories | 1954 | $3.6B | 6,200 | - |
| Cyberonics | 1987 | $291.6M | 660 | - |
| Shire Pharmaceuticals Inc | 2004 | $15.2B | 3,500 | - |
SmithKline Beecham Holdings Corporation history FAQs
Zippia gives an in-depth look into the details of SmithKline Beecham Holdings Corporation, including salaries, political affiliations, employee data, and more, in order to inform job seekers about SmithKline Beecham Holdings Corporation. The employee data is based on information from people who have self-reported their past or current employments at SmithKline Beecham Holdings Corporation. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by SmithKline Beecham Holdings Corporation. The data presented on this page does not represent the view of SmithKline Beecham Holdings Corporation and its employees or that of Zippia.
SmithKline Beecham Holdings Corporation may also be known as or be related to SmithKline Beecham Holdings Corporation.